Skip to content

Clinical Study on Navigated Transcranial Magnetic Stimulation for Post-Stroke Upper Limb Dysfunction Based on Brain Network Mapping

Clinical Study on Navigated Transcranial Magnetic Stimulation for Post-Stroke Upper Limb Dysfunction Based on Brain Network Mapping

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500110101
Enrollment
Unknown
Registered
2025-09-30
Start date
2025-10-15
Completion date
Unknown
Last updated
2025-10-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stroke

Interventions

Precision Positioning Group:Repetitive transcranial magnetic stimulation (rTMS) will be administered based on individualized brain network characteristics to determine the stimulation target. The trea
Regular Positioning Group:Stimulation will be applied to the conventional primary motor cortex (M1) once daily, five times per week, for a total of three consecutive weeks

Sponsors

Yongzhou Central Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Meets the "Stroke" diagnostic criteria established by the 4th National Academic Conference on Cerebrovascular Diseases; 2. Diagnosed with unilateral ischemic/hemorrhagic stroke confirmed by CT/MRI; 3. Aged 18–80 years, any gender; 4. Conscious, with stable vital signs and the ability to maintain static sitting balance; 5. Disease duration <=12 months, all first-time incidents; 6. Presence of clear post-stroke upper limb dysfunction (PSUD), with upper limb stages of Brunnstrom II–V; 7. First onset of stroke; 8. Able to cooperate with assessments and sign the informed consent form.

Exclusion criteria

Exclusion criteria: 1. Concurrent participation in other clinical trials or inability to complete the full course of treatment; 2. Presence of secondary dysfunction due to epilepsy, severe cardiovascular disease, or endocrine disorders; 3. Upper limb amputation or other conditions affecting upper limb function; 4. Contraindications to MRI scanning (e.g., patients with cardiac pacemakers, intracranial aneurysm clips post-surgery, or ferromagnetic implants); 5. Contraindications to rTMS therapy (e.g., intracranial metal implants, cardiac pacemakers, cochlear implants, or elevated intracranial pressure); 6. Previous history of electroconvulsive therapy or rTMS treatment.

Design outcomes

Primary

MeasureTime frame
Fugl-Meyer Assessment for the Upper Extremity(FMA-UE);Motor Evoked Potential (MEP);centralmotor condition time(CMCT);fractional anisotropy(FA);centralmotor condition time(CMCT);Corticospinal Tract - Fractional Anisotropy Asymmetry Index(CST-FAAI);

Secondary

MeasureTime frame
Action Research Arm Test(ARAT);modified Barthel Index(MBI);

Countries

China

Contacts

Public ContactXiong Mingyue

Yongzhou Central Hospital

xiongmingyue2182@163.com+86 150 7460 6022

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026